Éric Ouattara

964 total citations
23 papers, 337 citations indexed

About

Éric Ouattara is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Éric Ouattara has authored 23 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Éric Ouattara's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (6 papers). Éric Ouattara is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (6 papers). Éric Ouattara collaborates with scholars based in France, Ivory Coast and United States. Éric Ouattara's co-authors include Xavier Anglaret, Christine Danel, Raoul Moh, Delphine Gabillard, Serge Eholié, Didier Koumavi Ekouévi, Anani Badjé, Kévin Jean, Serge Eholié and Rochelle P. Walensky and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and American Journal of Epidemiology.

In The Last Decade

Éric Ouattara

22 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éric Ouattara France 11 230 151 71 70 40 23 337
Özlem Altuntaş Aydın Türkiye 11 186 0.8× 161 1.1× 54 0.8× 48 0.7× 24 0.6× 46 289
Fizza S. Gillani United States 15 429 1.9× 318 2.1× 46 0.6× 99 1.4× 33 0.8× 51 556
Hayat Kumbasar Karaosmanoğlu Türkiye 11 155 0.7× 167 1.1× 40 0.6× 44 0.6× 25 0.6× 45 277
Gheorghiță Jugulete Romania 8 178 0.8× 128 0.8× 39 0.5× 66 0.9× 23 0.6× 42 310
S Murad United Kingdom 5 211 0.9× 166 1.1× 26 0.4× 29 0.4× 30 0.8× 7 351
Maria Letícia Santos Cruz Brazil 11 152 0.7× 100 0.7× 57 0.8× 71 1.0× 41 1.0× 24 301
James G. Carlucci United States 10 217 0.9× 145 1.0× 29 0.4× 42 0.6× 62 1.6× 36 394
Banafsheh Moradmand Badie Iran 10 247 1.1× 124 0.8× 48 0.7× 31 0.4× 13 0.3× 29 405
Fabienne Caby France 9 232 1.0× 92 0.6× 123 1.7× 231 3.3× 14 0.3× 26 365
Sonya Davey United States 6 178 0.8× 49 0.3× 53 0.7× 58 0.8× 66 1.6× 12 289

Countries citing papers authored by Éric Ouattara

Since Specialization
Citations

This map shows the geographic impact of Éric Ouattara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Ouattara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Ouattara more than expected).

Fields of papers citing papers by Éric Ouattara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Ouattara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Ouattara. The network helps show where Éric Ouattara may publish in the future.

Co-authorship network of co-authors of Éric Ouattara

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Ouattara. A scholar is included among the top collaborators of Éric Ouattara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Ouattara. Éric Ouattara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blin, Patrick, et al.. (2025). Comparative effectiveness of robot-assisted vs. open prostatectomy: a real-life nationwide study. World Journal of Urology. 43(1). 367–367. 1 indexed citations
2.
Müller, J., F. Binder-Foucard, Amélie Bruandet, et al.. (2022). Major interregional differences in France of COVID-19 hospitalization and mortality from January to June 2020. Revue d Épidémiologie et de Santé Publique. 70(6). 265–276. 3 indexed citations
3.
Prévost, Blandine, F. Binder-Foucard, Amélie Bruandet, et al.. (2022). Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France. Frontiers in Pediatrics. 10. 975826–975826. 5 indexed citations
4.
Ouattara, Éric, Camille Tumiotto, Harald Wodrich, et al.. (2022). Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France. Journal of Clinical Virology. 149. 105134–105134.
5.
Ouattara, Éric, Amélie Bruandet, Xavier Lenne, et al.. (2021). Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database. BMJ Open Respiratory Research. 8(1). e001002–e001002. 9 indexed citations
6.
Benmarhnia, Tarik, et al.. (2020). Temporal trends in socioeconomic inequalities in HIV testing: an analysis of cross-sectional surveys from 16 sub-Saharan African countries. The Lancet Global Health. 8(6). e808–e818. 29 indexed citations
7.
Ouattara, Éric, Christine Danel, Ethan D. Borre, et al.. (2019). Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis. PLoS ONE. 14(6). e0219068–e0219068. 10 indexed citations
8.
Boyd, Anders, Raoul Moh, Anani Badjé, et al.. (2017). Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication. Clinical Infectious Diseases. 66(1). 112–120. 45 indexed citations
9.
Ouattara, Éric, Alexandre Duvignaud, R. Migliani, et al.. (2017). Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program. PLoS neglected tropical diseases. 11(11). e0006060–e0006060. 18 indexed citations
10.
Danel, Christine, Timothée Ouassa, Éric Ouattara, et al.. (2017). Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Côte d'Ivoire. PLoS ONE. 12(7). e0181995–e0181995. 20 indexed citations
11.
Guéhi, Calixte, Anani Badjé, Delphine Gabillard, et al.. (2016). High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Research and Therapy. 13(1). 12–12. 53 indexed citations
12.
Ouattara, Éric, Marion Robine, Serge Eholié, et al.. (2016). Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies. Clinical Infectious Diseases. 62(11). 1454–1462. 13 indexed citations
13.
Jean, Kévin, Marie‐Claude Boily, Christine Danel, et al.. (2016). What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial. American Journal of Epidemiology. 184(10). 755–760. 1 indexed citations
14.
Ouattara, Éric, Eric L. Ross, Yazdan Yazdanpanah, et al.. (2014). Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(3). 294–302. 5 indexed citations
15.
Danel, Christine, Mathieu Kabran, André Inwoley, et al.. (2014). Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa. PLoS ONE. 9(10). e107245–e107245. 7 indexed citations
16.
Ouattara, Éric, Christine Danel, Raoul Moh, et al.. (2013). Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. Journal of the International AIDS Society. 16(1). 18059–18059. 4 indexed citations
17.
Messou, Eugène, Marie‐Laure Chaix, Delphine Gabillard, et al.. (2013). Increasing Rate of TAMs and Etravirine Resistance in HIV-1–Infected Adults Between 12 and 24 Months of Treatment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(2). 211–219. 20 indexed citations
18.
Ouattara, Éric, Xavier Anglaret, Angela Y. Wong, et al.. (2012). Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age. AIDS. 26(5). 625–634. 12 indexed citations
19.
Anglaret, Xavier, Callie A. Scott, Rochelle P. Walensky, et al.. (2012). Could Early Antiretroviral Therapy Entail More Risks than Benefits in Sub-Saharan African HIV-Infected Adults? A Model-Based Analysis. Antiviral Therapy. 18(1). 45–55. 17 indexed citations
20.
Ekouévi, Didier Koumavi, Patrick Coffié, Éric Ouattara, et al.. (2010). Pregnancy Outcomes in Women Exposed to Efavirenz and Nevirapine: An Appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(2). 183–187. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026